Inzagen Ltd

Inzagen is focused on the development of a marketed therapeutic product, with potential applications in many therapeutic areas, to introduce to the European and North American markets. Inzagen has the rights to this development via an in-licensing arrangement with Amsha Therapeutics. The company's strategy is to develop the product and negotiate agreements with Licensees for exclusive access to either territories and/or clinical indications, for the markets of the EU and the USA. Inzagen was founded by a team with broad experience of the pharmaceutical and biotech industry. The team has a focus on commercialisation and deal-making, along with expertise in technology transfer and product ( www.inzagen.com )